Thomas M. Marti
Bern, BE 3008, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances.
Journal: Military Medical Research
Published: June 30, 2026
Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Journal: EMBO molecular medicine
Published: December 11, 2025
A novel alveoli-on-chip platform for modeling cyclic stretch in patient-derived alveolar epithelial cells cultured from organoids.
Journal: Lab on a chip
Published: November 07, 2025
Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage.
Journal: British journal of cancer
Published: July 25, 2025
Lactate-activated astrocytes promote NSCLC brain metastasis through extracellular vesicle-mediated miR-8085/TRIM67/ELK1 signaling axis.
Journal: Cellular & molecular biology letters
Published: June 25, 2025
POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis.
Journal: Redox biology
Published: June 11, 2025
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2025
Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma.
Journal: Oncogenesis
Published: April 16, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Journal: EMBO molecular medicine
Published: March 06, 2025
Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.
Journal: Respiratory research
Published: November 14, 2024
Last Updated: 09/26/2026